JP2014518226A5 - - Google Patents

Download PDF

Info

Publication number
JP2014518226A5
JP2014518226A5 JP2014517519A JP2014517519A JP2014518226A5 JP 2014518226 A5 JP2014518226 A5 JP 2014518226A5 JP 2014517519 A JP2014517519 A JP 2014517519A JP 2014517519 A JP2014517519 A JP 2014517519A JP 2014518226 A5 JP2014518226 A5 JP 2014518226A5
Authority
JP
Japan
Prior art keywords
drug
group
crystalline form
acetate
hexane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014517519A
Other languages
English (en)
Japanese (ja)
Other versions
JP6276689B2 (ja
JP2014518226A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/002839 external-priority patent/WO2013007361A1/en
Publication of JP2014518226A publication Critical patent/JP2014518226A/ja
Publication of JP2014518226A5 publication Critical patent/JP2014518226A5/ja
Application granted granted Critical
Publication of JP6276689B2 publication Critical patent/JP6276689B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014517519A 2011-07-08 2012-07-06 結晶性(1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミン Active JP6276689B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11005587 2011-07-08
EP11005587.8 2011-07-08
PCT/EP2012/002839 WO2013007361A1 (en) 2011-07-08 2012-07-06 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017003194A Division JP6559165B2 (ja) 2011-07-08 2017-01-12 結晶性(1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミン

Publications (3)

Publication Number Publication Date
JP2014518226A JP2014518226A (ja) 2014-07-28
JP2014518226A5 true JP2014518226A5 (cg-RX-API-DMAC7.html) 2015-11-05
JP6276689B2 JP6276689B2 (ja) 2018-02-07

Family

ID=46717800

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014517519A Active JP6276689B2 (ja) 2011-07-08 2012-07-06 結晶性(1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミン
JP2017003194A Active JP6559165B2 (ja) 2011-07-08 2017-01-12 結晶性(1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017003194A Active JP6559165B2 (ja) 2011-07-08 2017-01-12 結晶性(1r,4r)−6’−フルオロ−N,N−ジメチル−4−フェニル−4’,9’−ジヒドロ−3’H−スピロ[シクロヘキサン−1,1’−ピラノ[3,4,b]インドール]−4−アミン

Country Status (23)

Country Link
US (2) US8618156B2 (cg-RX-API-DMAC7.html)
EP (2) EP3235821B1 (cg-RX-API-DMAC7.html)
JP (2) JP6276689B2 (cg-RX-API-DMAC7.html)
CN (2) CN106939005A (cg-RX-API-DMAC7.html)
AR (1) AR087081A1 (cg-RX-API-DMAC7.html)
AU (2) AU2012283449B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014000358A2 (cg-RX-API-DMAC7.html)
CA (1) CA2841032C (cg-RX-API-DMAC7.html)
CY (1) CY1120525T1 (cg-RX-API-DMAC7.html)
DK (2) DK2729470T3 (cg-RX-API-DMAC7.html)
EA (1) EA026750B1 (cg-RX-API-DMAC7.html)
ES (1) ES2641299T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20170968T1 (cg-RX-API-DMAC7.html)
HU (1) HUE033043T2 (cg-RX-API-DMAC7.html)
IL (1) IL230331B (cg-RX-API-DMAC7.html)
LT (1) LT2729470T (cg-RX-API-DMAC7.html)
MX (1) MX2014000297A (cg-RX-API-DMAC7.html)
PL (1) PL2729470T3 (cg-RX-API-DMAC7.html)
PT (1) PT2729470T (cg-RX-API-DMAC7.html)
RS (1) RS56343B1 (cg-RX-API-DMAC7.html)
SI (1) SI2729470T1 (cg-RX-API-DMAC7.html)
TW (1) TWI585092B (cg-RX-API-DMAC7.html)
WO (1) WO2013007361A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014000297A (es) * 2011-07-08 2014-01-31 Grünenthal GmbH (1r,4r)-6´-fluoro-n,n-dimetil-4-fenil-4´,9´dihidro-3´h-espiro[cic lohexan-1,1´-piran[3,4,b]indol]-4-amina cristalina.
CA2974578C (en) 2015-01-23 2020-11-17 Grunenthal Gmbh Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function
US20180021304A1 (en) 2015-02-02 2018-01-25 Ratiopharm Gmbh Composition comprising cebranopadol in a dissolved form
CN118286209A (zh) 2016-02-29 2024-07-05 帕克治疗公司 西博帕多的滴定
EP3981759A4 (en) * 2019-05-21 2023-07-19 Jiangsu Forefront Pharmaceutical Co., Ltd. NEW CRYSTALLINE FORM OF A SODIUM TREPROSTINIL SALT AND METHOD FOR PREPARING IT
CN112254496A (zh) * 2020-09-25 2021-01-22 榆林学院 一种煤泥收集装置
WO2024129782A1 (en) 2022-12-12 2024-06-20 Park Therapeutics, Inc. Regimens and compositions useful for alleviating pain
WO2024173714A1 (en) 2023-02-15 2024-08-22 Park Therapeutics, Inc. Regimens and compositions useful for alleviating pain

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10252667A1 (de) * 2002-11-11 2004-05-27 Grünenthal GmbH Spirocyclische Cyclohexan-Derivate
DE102005016460A1 (de) * 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006033109A1 (de) * 2006-07-18 2008-01-31 Grünenthal GmbH Substituierte Heteroaryl-Derivate
DE102006046745A1 (de) 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
DK2600851T3 (en) * 2010-08-04 2018-06-25 Gruenenthal Gmbh PHARMACEUTICAL DOSAGE FORM CONTAINING 6'-FLUORO- (N-METHYL OR N, N-DIMETHYL -) - 4-PHENYL-4 ', 9'-DIHYDRO-3'H-SPIRO [CYCLOHEXAN-1,1'-PYRANO [3,4, B] INDOL] -4-AMINE FOR TREATMENT OF NEUROPATHIC PAIN
MX2014000297A (es) * 2011-07-08 2014-01-31 Grünenthal GmbH (1r,4r)-6´-fluoro-n,n-dimetil-4-fenil-4´,9´dihidro-3´h-espiro[cic lohexan-1,1´-piran[3,4,b]indol]-4-amina cristalina.

Similar Documents

Publication Publication Date Title
JP2014518226A5 (cg-RX-API-DMAC7.html)
JP2014506907A5 (cg-RX-API-DMAC7.html)
JP2008533007A5 (cg-RX-API-DMAC7.html)
JP2014523445A5 (cg-RX-API-DMAC7.html)
JP2012255026A5 (cg-RX-API-DMAC7.html)
JP2016512531A5 (cg-RX-API-DMAC7.html)
JP2010077141A5 (cg-RX-API-DMAC7.html)
JP2018534348A5 (cg-RX-API-DMAC7.html)
MX2012009079A (es) Formulaciones de rasagilina de liberación prolongada y usos de las mismas.
JP2014507455A5 (cg-RX-API-DMAC7.html)
JP2017518334A5 (cg-RX-API-DMAC7.html)
NZ590291A (en) Pharmaceutical compositions for treatment of parkinson's disease
JP2012530779A5 (cg-RX-API-DMAC7.html)
JP2012502037A5 (cg-RX-API-DMAC7.html)
JP2014505107A5 (cg-RX-API-DMAC7.html)
JP2010534220A5 (cg-RX-API-DMAC7.html)
JP2012533565A5 (cg-RX-API-DMAC7.html)
JP2013514980A5 (cg-RX-API-DMAC7.html)
JP2015522630A5 (cg-RX-API-DMAC7.html)
JP2016511753A5 (cg-RX-API-DMAC7.html)
JP2014505017A5 (cg-RX-API-DMAC7.html)
JP2017537954A5 (cg-RX-API-DMAC7.html)
JP2016515550A5 (cg-RX-API-DMAC7.html)
JP2013513607A5 (cg-RX-API-DMAC7.html)
JP2009040767A5 (cg-RX-API-DMAC7.html)